Prevalence Surveys of Antimicrobial Use in Hospitals: Purpose, Practicalities, and Pitfalls

  • R. Andrew Seaton


Antimicrobials are widely used in hospitals for a broad range of conditions by a variety of specialists. Prescribing is largely empiric and is dependent on the recognition of clinical syndromes and the prescribers’ experience, including their own awareness of likely causative microbes, local resistance profiles and their knowledge of antimicrobial therapy. As the majority of prescribers work in system-based specialities, their interest and expertise in microbiology and antimicrobial therapy is variable.1 These factors may at least partly explain the observed variation and quality in prescribing practice.


Antimicrobial Therapy Prevalence Survey Infection Specialist Clinical Pharmacy Service Antimicrobial Prescribe 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Srinivasan S, Song X, Richards A, Sinkowitz-Cochran R, Cardo D, Rand C. A survey of knowledge, attitudes, and beliefs of house staff physicians from various specialities concerning antimicrobial use and resistance. Arch Intern Med 2004;164:1451–1456.CrossRefPubMedGoogle Scholar
  2. 2.
    Davey P G, Parker S E, Orange G, Malek M, Dodd T. Prospective audit costs and outcome of aminoglycoside treatment and of therapy for Gram-negative bacteraemia. J Antimicrob Chemother 1995;36:561–575.CrossRefPubMedGoogle Scholar
  3. 3.
    Dunagan W C, Woodward R S, Medoff G, et al. Antibiotic misuse in two clinical situations: Positive blood cultures and administration of aminoglycosides. Rev Infect Dis 1991;13:405–412.PubMedGoogle Scholar
  4. 4.
    Seaton RA, Nathwani D. Rationale for sepsis management in immunocompetent adults. Proc R Coll Physicians Edinburgh 2000;30:11–19.Google Scholar
  5. 5.
    McLaughlin CM, Bodasing N, Boyter A, Fenelon C, Fox JG, Seaton RA Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: An intervention study. Q J Med 2005;98:745–752.Google Scholar
  6. 6.
    Ansari F, Gray K, Nathwani D, et al Outcomes of an intervention to improve hospital antibiotic prescribing: Interrupted time series with segmented regression analysis. J Antimicrob Chemother, 2003;52:842–848.CrossRefPubMedGoogle Scholar
  7. 7.
    Grayson M L, Melvani S, Kirsa S W, et al. Impact of an electronic antibiotic advice and approval system on antibiotic prescribing in an Australian teaching hospital. Med J Aust 2004;180:455–458.PubMedGoogle Scholar
  8. 8.
    Fraser GL, Stogsdil P, Dickens JD, et al. Antibiotic optimisation. An evaluation of patient safety and economic outcomes. Arch Intern Med 1997;157:1689–1694.CrossRefPubMedGoogle Scholar
  9. 9.
    Gomez J, Conde Cavero SJ, Hernandez Cardona JL, et al. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother, 1996;38:309–314.CrossRefPubMedGoogle Scholar
  10. 10.
    Byl B, Clevenbergh P, Jacobs F, et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteraemia. Clin Infect Dis, 1999;29:60–66.CrossRefPubMedGoogle Scholar
  11. 11.
    Nathwani D, Davey P, France A J, et al. Impact of an infection consultation service for bacteraemia on clinical management and use of resources. Q J Med 1996;89:789–797.Google Scholar
  12. 12.
    Nathwani D and on behalf of Scottish Medicines Consortium (SMC) Short Life Working Group, The Scottish Executive Health Department Healthcare Associated Infection Task Force. Antimicrobial prescribing policy and practice in Scotland: Recommendations for good antimicrobial practice in acute hospitals. J Antimicrob Chemother 2006;57:1189–1196.CrossRefPubMedGoogle Scholar
  13. 13.
    World Health Organisation. ATC index with DDDs. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology, 2003. Available at:
  14. 14.
    Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858–873.CrossRefPubMedGoogle Scholar
  15. 15.
    McCabe WR, Jackson GG. Gram-negative bacteraemia. Arch Intern Med 1962;110;92–100.Google Scholar
  16. 16.
    Leibovici L, Shraga I, Drucker M, et al. The benefit of appropriate antimicrobial treatment in patients bloodstream infection. J Intern Med 1998;244:379–386.CrossRefPubMedGoogle Scholar
  17. 17.
    Seaton RA, Nathwani D, Phillips G, et al. Clinical record keeping in patients receiving antibiotics in general medical wards. Health Bull, 1999;57:28–33.Google Scholar
  18. 18.
    Meehan TP, Fine MJ, Krumholtz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997;278:2080–2084.CrossRefPubMedGoogle Scholar
  19. 19.
    Ali MZ, Goetz MB. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997;24:796–809.PubMedGoogle Scholar
  20. 20.
    Harbarth S, Garbino J, Pugin J, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003;115:529–535.CrossRefPubMedGoogle Scholar
  21. 21.
    Sevinc F, Prins JM, Koopmans RP, et al. Early switch from intravenous to oral antibiotics: Guidelines and implementation in a large teaching hospital. J Antimicrob Chemother, 1999;43:601–606.CrossRefPubMedGoogle Scholar
  22. 22.
    Laing RBS, MacKenzie AR, Shaw H, Gould IM, Douglas JG. The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards. J Antimicrob Chemother, 1998;42:107–11.CrossRefPubMedGoogle Scholar
  23. 23.
    Chan R, Hemeryck L, O’Regan M, Clancy L, Feely J. Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: Open, randomised controlled trial. Br Med J 1995;310:1360–1362.Google Scholar
  24. 24.
    Fowler VG, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteraemia according to compliance with recommendations of infectious diseases specialists; experience with 244 patients. Clin Infect Dis 1998;27:478.CrossRefPubMedGoogle Scholar
  25. 25.
    Al-Eidan FA, McElnay JC, Scott MG, et al. Use of a treatment protocol in the management of community acquired lower respiratory tract infection. J Antimicrob Chemother 2000;45:387–394.CrossRefPubMedGoogle Scholar
  26. 26.
    Gross R, Morgan AS, Kinky DE, et al. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis, 2001;33:289–295.CrossRefPubMedGoogle Scholar
  27. 27.
    White AC, Atmar RL, Wilson J, et al Effects of requiring prior authorisation for selected antimicrobials: Expenditures, susceptibilities and clinical outcomes. Clin Infect Dis 1997;25:230–239.CrossRefPubMedGoogle Scholar
  28. 28.
    MacKenzie FM, Struelens MJ, Towner KJ, Gould IM, on behalf of the ARPAC Steering Group and the ARPAC Consensus Conference Participants. Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC). Clin Microbiol Infect 2005;11:938–954.CrossRefPubMedGoogle Scholar
  29. 29.
    Seto W-H, Ching T-Y, Kou M, et al. Hospital antibiotic prescribing successfully modified by immediate concurrent feedback. Br J Clin Pharmacd 1996;41:229–234.CrossRefGoogle Scholar
  30. 30.
    Seaton RA, Bell, E, Gourlay Y, Semple L. Nurse-led management of uncomplicated cellulitis in the community; evaluation of a protocol incorporating intravenous ceftriaxone. J Antimicrob Chemother 2005;55:764–767.CrossRefPubMedGoogle Scholar
  31. 31.
    Martinez MJ, Freire A, Castro I, et al Clinical and economic impact of a pharmacist-intervention to promote sequential intravenous to oral clindamycin conversion. Pharm World Sci 2000;22:53–58.CrossRefPubMedGoogle Scholar
  32. 32.
    Skoog G, Cars O, Skarlund K et al. Large scale nationwide point prevalence study of indications for antibiotic use in 54 Swedish hospitals in 2003. Clin Microbiol Inf. 2004; 10 (supp 3): 326Google Scholar
  33. 33.
    Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644–1655.CrossRefPubMedGoogle Scholar
  34. 34.
    British Thoracic Society. Guidelines for the management of community acquired pneumonia in adults. Thorax 2001;56 (suppl IV):1–55.Google Scholar
  35. 35.
    Seaton RA, Nathwani D, Burton P, et al. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT). Int J Antimicrob Ag (2007); 29:693–699.CrossRefGoogle Scholar
  36. 36.
    Knox K, Lawson W, Dean B, Holmes A Multidisciplinary antimicrobial management and the role of the infectious diseases pharmacist—A UK perspective. J Hosp Infect 2003;53:85–90.CrossRefPubMedGoogle Scholar
  37. 37.
    Dean B, Lawson W, Jacklin A, Rogers T, Azadian B, Holmes A. The use of serial point-prevalence studies to investigate hospital anti-infective prescribing. Int J Pharm Pract 2002;10:121–125.Google Scholar
  38. 38.
    Gould IM, Jappy B. Trends in hospital prescribing after introduction of an antibiotic policy. J Antimicrob Chemother 1996;38:895–904.CrossRefPubMedGoogle Scholar
  39. 39.
    Nathwani D, Rubinstein E, Barlow G, Davey P. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care? Clin Infect Dis 2001;32:728–740.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • R. Andrew Seaton
    • 1
  1. 1.Infectious Diseases Unit, Brownlee CentreGartnavel General HospitalGlasgowScotland

Personalised recommendations